At the end of October, Lilly itself announced that the pharmaceutical group saw good opportunities for the approval of the companys new weight loss pill under development to receive a so-called fast track from the FDA
Patients can feel confident knowing they are receiving legitimate, safe medications and that their treatment is grounded in established clinical standards
Szeinberg A, Sheba C, Adam A
Lehman1,4,5 1 Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, USA 2 Department of Neurological Surgery, University of Louisville, Louisville, KY, USA 3 Department of Internal Medicine, University of Louisville, Louisville, KY, USA 4 The Brown Cancer Center, University of Louisville, Louisville, KY, USA 5 Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY, USA 6 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA Corresponding author: Norman L